No takes yet. Share an insight, caveat, or question.
Randomized trial shows doxorubicin induces growth changes in mammary tumors, suggesting its effectiveness in chemotherapy.
Safa et al. (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: